Zerenia Clinics UK is based in London and will be offering in-person and online appointments.
Eurox has started the white label sale of its dronabinol products to a number of select customers.
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
Tilray will supply a variety of its pharmaceutical-grade medical cannabis products.
Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan Drug Designation for QIXLEEF.
Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
The deal will see the companies develop new products to target specific medical conditions.
MGC Pharma has signed a Supply and Distribution Agreement with AMC Holdings.
CBD Science has announced the launch of a funding raise to help advance cannabis-based treatments for cancer pain.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
